UK Markets close in 8 hrs 25 mins

Corcept Therapeutics Incorporated (0I3Q.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
18.23-2.61 (-12.52%)
As of 03:14PM GMT. Market open.
Full screen
Previous close20.84
Bid0.00 x 0
Ask0.00 x 0
Day's range22.56 - 22.56
52-week range22.56 - 22.56
Avg. volumeN/A
Market cap1.818B
Beta (5Y monthly)0.74
PE ratio (TTM)23.37
EPS (TTM)0.78
Earnings date07 Feb 2022 - 11 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Why Is Corcept (CORT) Up 6.6% Since Last Earnings Report?

    Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Zacks

    Corcept's (CORT) Q3 Earnings Beat Estimates, Revenues Miss

    Corcept's (CORT) earnings beat estimates in the third quarter of 2021 while revenues miss the same. The company tightens its revenue guidance for 2021.

  • Motley Fool

    Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript

    Statements during this call, other than statements of historical facts, are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties which may cause actual results to differ materially from those such statements express or imply. The availability of competing treatments, including generic versions of Korlym, our ability to obtain acceptable prices or adequate insurance coverage and reimbursement for Korlym, risks related to the development of our product candidates, including their clinical attributes, regulatory approvals, mandates and oversights and other requirements, and the scope and protective power of our intellectual property.